A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME3) trial

A. H. Tavenier, R. S. Hermanides*, J. P. Ottervanger, S. Rasoul, R. J. Slingerland, R. Tolsma, S. van Workum, E. Kedhi, A. W. J. van 't Hof

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalNetherlands Heart Journal
Volume27
Issue number4
DOIs
Publication statusPublished - Apr 2019

Keywords

  • ST-elevation myocardial infarction
  • Ticagrelor
  • Platelet inhibition
  • Primary percutaneous coronary intervention
  • Fentanyl
  • PERCUTANEOUS CORONARY INTERVENTION
  • TREATMENT PLATELET REACTIVITY
  • SEGMENT ELEVATION
  • MORPHINE USE
  • CARDIOVASCULAR EVENTS
  • INTRAVENOUS FENTANYL
  • TASK-FORCE
  • ACETAMINOPHEN
  • AGGREGATION
  • ASSOCIATION

Cite this